Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CYLD | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RHOH | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PIGY | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | E2F7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SLC22A18AS | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | IFT52 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | TMEM62 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ARHGEF16 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | RNF222 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | FSD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |